Ani Pharmaceuticals Inc financial data

Symbol
ANIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
210 Main Street West, Baudette, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
BIOSANTE PHARMACEUTICALS INC (to 7/18/2013), BEN ABRAHAM TECHNOLOGIES INC (to 12/23/1999)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 349 % +1.11%
Quick Ratio 81.4 % -6.45%
Debt-to-equity 125 % +7.38%
Return On Equity -1.62 % -145%
Return On Assets -0.7 % -143%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 824M USD +121%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 19.4M shares +2.76%
Weighted Average Number of Shares Outstanding, Diluted 19.4M shares +1.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 555M USD +23.6%
Research and Development Expense 37.8M USD +27.5%
Costs and Expenses 544M USD +33.5%
Operating Income (Loss) 11.7M USD -72.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.5M USD -157%
Income Tax Expense (Benefit) -412K USD -124%
Net Income (Loss) Attributable to Parent -7.09M USD -153%
Earnings Per Share, Basic -0.53 USD/shares -200%
Earnings Per Share, Diluted -0.54 USD/shares -206%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 145M USD -24.9%
Accounts Receivable, after Allowance for Credit Loss, Current 196M USD +9.8%
Inventory, Net 148M USD +38.9%
Assets, Current 521M USD +4.84%
Deferred Income Tax Assets, Net 67.7M USD -19.8%
Property, Plant and Equipment, Net 56.7M USD +28.3%
Intangible Assets, Net (Excluding Goodwill) 570M USD +159%
Goodwill 60.4M USD +114%
Other Assets, Noncurrent 11.5M USD -28.6%
Assets 1.29B USD +44.7%
Accounts Payable, Current 60.9M USD +78.7%
Employee-related Liabilities, Current 29.8M USD +94.3%
Accrued Liabilities, Current 17.8M USD +241%
Contract with Customer, Liability, Current 5M USD
Liabilities, Current 190M USD +41.4%
Operating Lease, Liability, Noncurrent 4.11M USD +198%
Other Liabilities, Noncurrent 6.94M USD +32%
Liabilities 857M USD +96.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 5.37M USD -61.9%
Retained Earnings (Accumulated Deficit) -89.6M USD -10.8%
Stockholders' Equity Attributable to Parent 406M USD -5.56%
Liabilities and Equity 1.29B USD +44.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.3M USD -14.7%
Net Cash Provided by (Used in) Financing Activities -19.7M USD -334%
Net Cash Provided by (Used in) Investing Activities 8.93M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.48M USD -48.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 145M USD -24.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.95M USD +85.1%
Deferred Tax Assets, Valuation Allowance 400K USD 0%
Deferred Tax Assets, Gross 102M USD +11.3%
Operating Lease, Liability 5.67M USD +175%
Payments to Acquire Property, Plant, and Equipment 4.58M USD +95%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.8M USD -191%
Lessee, Operating Lease, Liability, to be Paid 6.66M USD +195%
Property, Plant and Equipment, Gross 77.5M USD +2.07%
Operating Lease, Liability, Current 1.56M USD +128%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.61M USD +85.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.97M USD +146%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 990K USD +410%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.29M USD +174%
Deferred Tax Assets, Operating Loss Carryforwards 2.9M USD -51.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.67M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.29M USD +1348%
Additional Paid in Capital 511M USD +0.87%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 53.3M USD +3.5%
Depreciation, Depletion and Amortization 50.9M USD +14.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%